SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    da Silva FC. Quality of life in prostatic cancer patients. Cancer. 1993; 72(12 Suppl): 38033806.
  • 2
    Talcott JA. Quality of life in early prostate cancer. Do we know enough to treat? Hematol Oncol Clin North Am. 1996; 10: 691701.
  • 3
    Altwein J, Ekman P, Barry M, et al. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology. 1997; 49(4A Suppl): 6676.
  • 4
    Litwin MS. Measuring health related quality of life in men with prostate cancer. J Urol. 1994; 152 (5 Pt 2): 18821887.
  • 5
    Potosky AL, Harlan LC, Stanford JL, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999; 91: 17191724.
  • 6
    Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology. 1995; 45: 10071013.
  • 7
    Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol. 1996; 14: 22582265.
  • 8
    Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer. 1997; 79: 19771986.
  • 9
    Arai Y, Okubo K, Aoki Y, et al. Patient-reported quality of life after radical prostatectomy for prostate cancer. Int J Urol. 1999; 6: 7886.
  • 10
    Yarbro CH, Ferrans CE. Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum. 1998; 25: 685693.
  • 11
    Sprangers MA. Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials. Cancer Treat Rev, 1996; 22 Suppl A: 5562.
  • 12
    Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. 1996; 14: 671679.
  • 13
    Albertsen PC, Nease RF Jr., Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol. 1998; 159: 158163.
  • 14
    Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA. 1993; 269: 26502658.
  • 15
    Beck JR, Kattan MW, Miles BJ. A critique of the decision analysis for clinically localized prostate cancer. J Urol. 1994; 152(5 Pt 2): 18941899.
  • 16
    Lubeck DP, Litwin MS, Henning JM, et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1996; 48: 773777.
  • 17
    Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2: 217227.
  • 18
    Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473483.
  • 19
    Ware JE, Kosinski M, Keller SD. SF-12: How to score the SF-12 physical and mental health summary scales. Boston, MA: The Health Institute, New England Medical Center, 1995.
  • 20
    Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951; 16: 297334.
  • 21
    Lubeck DP, Litwin MS, Henning JM, Carroll PR. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res. 1997; 6: 385392.
  • 22
    Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995; 273: 129135.
  • 23
    Litwin MS, Shpall AI, Dorey F, Nguyen TH. Quality-of-life outcomes in long-term survivors of advanced prostate cancer. Am J Clin Oncol. 1998; 21: 327332.
  • 24
    Litwin MS. Health related quality of life in older men without prostate cancer. J Urol. 1999; 161: 11801184.
  • 25
    Ware JE, Kosinski M, Keller SK. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Center, 1994.
  • 26
    Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10: 407415.
  • 27
    Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994; 47: 8187.
  • 28
    Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993; 31: 141154.
  • 29
    Krongrad A, Lai H, Burke MA, Goodkin K, Lai S. Marriage and mortality in prostate cancer. J Urol. 1996; 156: 16961702.
  • 1
    Penson DF, Litwin MS, Lubeck DP, Flanders S, Pasta DJ, Carroll PR. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prostate Cancer and Prostatic Diseases. 1998; 1: 134143.
  • 31
    Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol. 1998; 16: 275283.
  • 32
    Talcott JA, Rieker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 1997; 89: 11171123.
  • 33
    Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1999; 54: 503508.
  • 34
    Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the cancer of the prostate strategic urologic research endeavor. J Urol. 2000; 164: 19731977.
  • 35
    D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998; 280: 969974.